Viewing Study NCT01083966


Ignite Creation Date: 2025-12-24 @ 4:41 PM
Ignite Modification Date: 2026-01-02 @ 2:29 AM
Study NCT ID: NCT01083966
Status: SUSPENDED
Last Update Posted: 2025-04-09
First Post: 2010-03-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Super-Selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Vestibular Schwannoma
Sponsor: Northwell Health
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module